C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2006
11/29/2006	CN1871003A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1870990A Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2006	CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/29/2006	CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/29/2006	CN1286764C Non-heating clay composites for building materials
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141671 Biphenyl derivatives
11/28/2006	US7141667 reacting 2-nitrophenylacetic acid with 4-amino-N-phenylmethylpiperidine, to form 2-nitro-N-[1-(phenylmethyl)-4-piperidinyl]-phenylacetamide, then reducing, hydrogenation, cyclization and cleaving the benzyl protecting group, to form calcitonin gene-related peptide antagonists, for treatment of headaches
11/28/2006	US7141587 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/28/2006	US7141586 Nicotinamide derivatives useful as PDE4 inhibitors
11/28/2006	US7141585 Pyrazole derivatives
11/28/2006	US7141584 2-(substituted-phenyl)amino-imidazoline derivatives
11/28/2006	US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/28/2006	US7141581 Modulates and/or inhibits tyrosine kinase signal transduction; antiproliferative agents; treating, prevention of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141570 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
11/28/2006	US7141569 Antiviral pyrazolopyridine compounds
11/28/2006	US7141567 such as (7R,8R,9R)-8-hydroxy-2-methyl-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine; for treatment of gastrointestinal disorders
11/28/2006	US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006125130A1 Methods for synthesizing heterocyclic compounds
11/23/2006	WO2006124744A1 Bicyclic derivatives as modulators of ion channels
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006123792A1 Tri- or tetra-substituted-3-aminopyrrolidine derivatives
11/23/2006	WO2006123786A1 Cyanine coloring matter and optical recording medium
11/23/2006	WO2006123767A1 Method for producing asymmetric tetrasubstituted carbon atom-containing compound
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123667A1 Monoamine compound, charge-transporting material, and organic electroluminescent device
11/23/2006	WO2006123244A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006123113A2 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
11/23/2006	WO2006122955A1 New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.
11/23/2006	WO2006122926A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006122631A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators
11/23/2006	WO2006122408A1 Bir domain binding compounds
11/23/2006	WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
11/23/2006	WO2006096652A3 Process for preparing macrocyclic compounds
11/23/2006	WO2006084870A3 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	WO2006071538A3 Substituted biaryl analogues
11/23/2006	WO2006069155A3 Inhibitors of protein arginine methyl transferases
11/23/2006	WO2006044732A3 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
11/23/2006	WO2006044449A3 Cgrp receptor antagonists
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	WO2005102997A8 3,4-disubstituted maleimides for use as vascular damaging agents
11/23/2006	WO2005077050A3 Hiv integrase inhibitors
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264638 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
11/23/2006	US20060264635 Process for the preparation of moxifloxacin hydrochloride
11/23/2006	US20060264627 Heterocyclic hydrazones as novel anti-cancer agents
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264476 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile, antitumor agents
11/23/2006	US20060264475 Compounds, compositions and methods for inhibiting or treating hiv-1
11/23/2006	US20060264474 novel sulphonamide, sulphamate and sulphamide derivatives, comprising a m-disubstituted benzene or pyridine ring and a substituted pyrazole moiety, which inhibit the processing of APP by gamma -secretase, and hence are useful in the treatment or prevention of Alzheimer's disease
11/23/2006	US20060264463 Chemical compounds
11/23/2006	US20060264460 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same
11/23/2006	US20060264449 Compounds for modulation of kinesins as anticancer agents with administering
11/23/2006	US20060264443 Treatment of rheumatoid arthritis
11/23/2006	US20060264440 Pyrazoles and methods of making and using the same
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264430 Pyrazole derivative
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	US20060264417 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	DE102005019718A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
11/23/2006	CA2609288A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608766A1 2-amino-4-phenylquinazoline derivatives and the use thereof as hsp90 modulators
11/23/2006	CA2608718A1 1, 2, 4-triazole derivatives as vasopressin antagonists
11/23/2006	CA2608599A1 Bicyclic derivatives as modulators of ion channels
11/23/2006	CA2608468A1 Tri-, tetra-substituted-3-aminopyrrolidine derivative
11/23/2006	CA2608419A1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	CA2608324A1 Pyrolle derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	CA2608240A1 Multicyclic compounds and methods of their use
11/23/2006	CA2608009A1 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
11/23/2006	CA2605272A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
11/23/2006	CA2605050A1 Histone deacetylase inhibitors
11/22/2006	EP1724323A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724263A1 Basic amine compound and use thereof

1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 1080